This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics
3-5 November 2026
RAIAmsterdam, Netherlands

Ammar Ahmed, PhD
Senior Scientist, Chemical Development at AstraZeneca
Speaker

Profile

Ammar Ahmed is a Senior Scientist in the New Modalities Unit of Chemical Development at AstraZeneca. He completed his PhD in Chemistry at Imperial College London under the supervision of Prof. Edward Tate and continued his research in the same group as a Post-Doc Research Associate. During his time at Imperial College, he worked on various peptide-based projects. In 2023, he joined AstraZeneca, where he is responsible for the development of AZ peptide drug substances for late clinical stages and commercial use. Ammar is also an active member of the ACS Green Chemistry Institute Pharmaceutical Roundtable.